Efficacy and Safety of Diclofenac plus Capsaicin Gel in Patients with Acute Back/Neck Pain: A Multicenter Randomized Controlled Study

被引:19
|
作者
Predel, Hans-Georg [1 ]
Ebel-Bitoun, Caty [2 ]
Peil, Barbara [3 ]
Weiser, Thomas W. [4 ]
Lange, Robert [5 ]
机构
[1] German Sport Univ Cologne, Inst Cardiol & Sports Med, Cologne, Germany
[2] Sanofi Aventis, Consumer Hlth Care, Paris, France
[3] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
[4] Sanofi Aventis Deutschland GmbH, Consumer Hlth Care, Med Affairs, Frankfurt, Germany
[5] Sanofi Aventis Deutschland GmbH, Consumer Hlth Care, Global Med Affairs, Frankfurt, Germany
关键词
Acute back pain; Acute neck pain; Capsaicin; Dermatologic agents; Diclofenac; Pain intensity reduction; Pain on movement; Safety; TOPICAL CAPSAICIN; LOW-BACK; NECK; PERMEATION; MANAGEMENT; STRAIN; CREAM;
D O I
10.1007/s40122-020-00161-9
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction Back and neck pain are common musculoskeletal disorders. Topical non-steroidal anti-inflammatory drugs (NSAIDs) are frequently used to reduce pain and inflammation with fewer systemic side effects and drug interactions compared with oral NSAIDs. This study assessed efficacy and tolerability of a topical combination of capsaicin + diclofenac to treat acute back/neck pain. Methods In a randomized, double-blind, controlled, multicenter, parallel group trial, 746 patients were treated twice-daily for 5 days with diclofenac 2% + capsaicin 0.075%, diclofenac 2%, capsaicin 0.075% or placebo. Efficacy assessments included change and area under the curve in pain on movement for the worst procedure (POMWP), change in pressure algometry, and number of patients with decrease in POMWP of >= 30% and >= 50%. Adverse events (AEs) were recorded. Results Change in POMWP between baseline and day 2 evening, 1 h after drug application, demonstrates superiority of the combination (- 3.05 cm) versus diclofenac alone (- 2.33 cm) and placebo (- 2.45 cm), but not capsaicin alone (- 3.26 cm). AEs were consistent with known safety profiles. Conclusion Capsaicin alone and capsaicin + diclofenac showed superior benefit compared with placebo. However, diclofenac alone demonstrated efficacy comparable with placebo, and therefore its addition to capsaicin added no increased pain relief over capsaicin alone.
引用
收藏
页码:279 / 296
页数:18
相关论文
共 50 条
  • [41] Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial
    Rigoard, Philippe
    Basu, Surajit
    Desai, Mehul
    Taylor, Rod
    Annemans, Lieven
    Tan, Ye
    Johnson, Mary Jo
    Van den Abeele, Carine
    North, Richard
    Deruytter, Marc
    Vangeneugden, Johan
    Galan, Vincent
    Villareal, Armando
    van Eijs, Frank
    Buwembo, Joseph
    Noriega, David
    Bhatia, Sanjay
    Tallarico, Eric
    Remacle, Jean-Michel
    Bojanic, Stana
    To-Nhu Vu
    Raftopoulos, Christian
    Jaramillo, Santiago
    Eif, Marcus
    Yepes, Carlos
    Lopez, Adrian
    Van Havenbergh, Tony
    Houden, Timothy
    Burnette, Candice
    Edmiston, Bart
    Mehta, Neel
    March, Guillermo Garcia
    Lad, Shivanand P.
    Pilitsis, Julie
    PAIN, 2019, 160 (06) : 1410 - 1420
  • [42] The Efficacy and Safety of a Combination of Thiocolchicoside and Etoricoxib in Low Back Pain (ESCoTEL): A Randomized Active-Controlled Trial
    Karmakar, Arnab
    Arora, Sumit
    Singal, Rajat
    Mitra, Sandip
    Saha, Manipa
    Mitra, Monjori
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
  • [43] The efficacy and safety profile of capsaicin 8% patch versus 5% Lidocaine patch in patients with diabetic peripheral neuropathic pain: a randomized, placebo-controlled study of south Asian male patients
    Nadia Hussain
    Amira S. A. Said
    Farideh A. Javaid
    Amal Hussain Ibrahim Al Haddad
    Mudassir Anwar
    Zainab Khan
    Abdallah Abu-Mellal
    Journal of Diabetes & Metabolic Disorders, 2021, 20 : 271 - 278
  • [44] The efficacy and safety profile of capsaicin 8% patch versus 5% Lidocaine patch in patients with diabetic peripheral neuropathic pain: a randomized, placebo-controlled study of south Asian male patients
    Hussain, Nadia
    Said, Amira S. A.
    Javaid, Farideh A.
    Al Haddad, Amal Hussain Ibrahim
    Anwar, Mudassir
    Khan, Zainab
    Abu-Mellal, Abdallah
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2021, 20 (01) : 271 - 278
  • [45] A randomized controlled trial evaluating the short-term efficacy of a single-administration intramuscular injection with the fixed combination of thiocolchicoside-diclofenac versus diclofenac monotherapy in patients with acute moderate-to-severe low back pain
    Konstantinos Iliopoulos
    Panagiota Koufaki
    Stavros Tsilikas
    Kyriakos Avramidis
    Antonios Tsagkalis
    Clio Mavragani
    Elias Zintzaras
    BMC Musculoskeletal Disorders, 24
  • [46] A randomized controlled trial evaluating the short-term efficacy of a single-administration intramuscular injection with the fixed combination of thiocolchicoside-diclofenac versus diclofenac monotherapy in patients with acute moderate-to-severe low back pain
    Iliopoulos, Konstantinos
    Koufaki, Panagiota
    Tsilikas, Stavros
    Avramidis, Kyriakos
    Tsagkalis, Antonios
    Mavragani, Clio
    Zintzaras, Elias
    BMC MUSCULOSKELETAL DISORDERS, 2023, 24 (01)
  • [47] Effects of motion style acupuncture treatment in acute low back pain patients with severe disability: A multicenter, randomized, controlled, comparative effectiveness trial
    Shin, Joon-Shik
    Ha, In-Hyuk
    Lee, Jinho
    Choi, Youngkwon
    Kim, Me-riong
    Park, Byoung-Yoon
    Shin, Byung-Cheul
    Lee, Myeong Soo
    PAIN, 2013, 154 (07) : 1030 - 1037
  • [48] Efficacy and safety of intravenous fosphenytoin for patients with acute herpes zoster-associated pain: A placebo-controlled randomized trial
    Iseki, Masako
    Yamamoto, Takenobu
    Ogawa, Youichi
    Majima, Yuta
    Abe, Yoichiro
    Watanabe, Daisuke
    Amaya, Fumimasa
    Hasegawa, Toshio
    Inafuku, Kazuhiro
    Kosugi, Toshifumi
    Nomura, Yukiko
    Deguchi, Tokiko
    Hamada, Toshihisa
    Shimizu, Kenji
    Arai, Saori
    Takahashi, Morito
    Hamada, Izumi
    Ishikawa, Yuko
    Kawashima, Makoto
    JOURNAL OF DERMATOLOGY, 2024, 51 (02) : 234 - 242
  • [49] Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter, randomized, phase 2/3 study
    Montesinos, Pau
    Roboz, Gail J.
    Bulabois, Claude-Eric
    Subklewe, Marion
    Platzbecker, Uwe
    Ofran, Yishai
    Papayannidis, Cristina
    Wierzbowska, Agnieszka
    Shin, Ho Jin
    Doronin, Vadim
    Deneberg, Stefan
    Yeh, Su-Peng
    Ozcan, Mehmet Ali
    Knapper, Steven
    Cortes, Jorge
    Pollyea, Daniel A.
    Ossenkoppele, Gert
    Giralt, Sergio
    Doehner, Hartmut
    Heuser, Michael
    Xiu, Liang
    Singh, Indrajeet
    Huang, Fei
    Larsen, Julie S.
    Wei, Andrew H.
    LEUKEMIA, 2021, 35 (01) : 62 - 74
  • [50] Efficacy of Rifaximin Compared with Ciprofloxacin for the Treatment of Acute Infectious Diarrhea: A Randomized Controlled Multicenter Study
    Hong, Kyoung Sup
    Kim, You Sun
    Han, Dong Soo
    Choi, Chang Hwan
    Jang, Byung-Ik
    Park, Young-Sook
    Lee, Kang-Moon
    Lee, Soo Teik
    Kim, Hyun-Soo
    Kim, Joo Sung
    GUT AND LIVER, 2010, 4 (03) : 357 - 362